Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:Q86TM3 (cage)
 29,987 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

N-benzyl-3,11-azatricyclo[6.3.0.0]undecane and N-octyl-3,11-azatricyclo[6.3.0.0]undecane, two triquinane compounds containing an endocyclic nitrogen atom and differing side-chains, were synthesized by thermal 2 + 2 cycloreversion from the symmetric cage compound pentacyclo[5.4.0.0.0.0]undecane-8,11-dione. The conformation of the cyclic system showed close similarity with the conformation of the hydrate of 4-methyltricyclo[6.3.0.0]undeca-3,11-dione. Both N-benzyl-3,11-azatricyclo[6.3.0.0]undecane and N-octyl-3,11-azatricyclo[6.3.0.0]undecane showed similar suppressant activity on the Ca2+ action potential of guinea-pig papillary muscle--the benzyl (aromatic) derivative fully suppressed the action potential (AP) whilst the aliphatic (octyl) derivative suppressed the AP to about 50% at the same dosages. Similarly, both these compounds (irreversibly) suppressed the chronotropy of spontaneously contracting guinea-pig atria by approximately 30% at concentrations of 1 x 10(-5) M or more.
 ...
PMID:The biological activity of two symmetric amine derivatives of the cis-syn-cis triquinane system. 899 28

m-CPBA-promoted Baeyer-Villiger oxidation of pentacyclo[6.3.0.0(2,6).0(3,10).0(5,9)]undecan-4-one (1) afforded the corresponding lactone 2 in 93% yield. Lithium aluminum hydride promoted reduction of lactones 2, 6, and 9, performed in the presence of BF(3).OEt(2) reagent, afforded the corresponding cage ethers, i.e., 4, 7, and 10, respectively. Two methods that can be used to replace a cage C=O group by ether oxygen without concomitant rearrangement are delineated. A key step in the first of these methods employs m-CPBA promoted "double Criegee rearrangement", which was used to convert pentacyclo[6.3.0.0(2,6).0(3,10).0(5,9)]undecan-4-one diethyl acetal (11) into 7,9-dioxapentacyclo-[8.3.0.0(2,6).0(3,12).0(5,11)]tridecan-8-one (12). Subsequently, 12 was converted into 4-oxapentacyclo[6.3.0.0(2,6).0(3,10).0(5,9)]undecane (14) via a two-step reduction-dehydration reaction sequence. The second method utilized PhI(OAc)(2)-I(2) reagent to convert cage lactols 15 and 17 into the corresponding cage ethers, i.e., 14 and 2-oxaadamantane (18), respectively.
 ...
PMID:Synthesis of novel cage oxaheterocycles. 1130 Sep 3

The title compound, 6-(1,3-benzodithiol-2-ylidene)-5,7-dimethyl-1,2-diphenylpentacyclo[5.4.0.0(2,5).0(3,11).0(4,8)]undecane, C(32)H(28)S(2), with a C(1)-homobasketane framework, crystallizes in the P-1 space group with one molecule in the asymmetric unit. The two cyclobutane rings in the cage are in a puckered conformation. Due to the enhanced through-bond interaction of the phenyl pi systems involving a strained sigma bond, the (Ph-)C-C(-Ph) bond length is significantly extended, to 1.610 (3) A.
 ...
PMID:A molecule with a C1-homobasketane framework. 1135 71

A novel compound, 6-benzylamino-3-hydroxyhexacyclo [6.5.0.0(3, 7).0(4, 12).0(5, 10).0(9, 13)]-tridecane, was synthesized as part of an ongoing study to explore the ion channel activity of polycyclic cage amines. The known polycyclic calcium channel antagonist, 8-benzylamino-8, 11-oxapentacyclo [5.4.0.0(2, 6).0(3, 10).0(5, 9)]undecane (NGP 1-01) served as the lead compound and as a positive control for channel activity. The title compound inhibited calcium currents at test concentrations of 10 microM at depolarized membrane potentials (in the potential range where the L-type calcium channel inactivates). At the test concentrations modulating effects were also observed for sodium and the delayed rectifier potassium currents. Due to its activity at both Ca(2+) and Na(+) channels, this compound may offer utility as a cardiovascular and/or neuroprotecting agent.
 ...
PMID:The structure and ion channel activity of 6-benzylamino-3-hydroxyhexa-cyclo[6.5.0.0(3,7).0(4,12).0(5,10).0(9,13]tridecane. 1276 66

[reaction: see text] Intramolecular 1,3-dipolar cycloadditions of cinchona azides to the C10-C11 alkyne and C10-C11 olefin unit of the alkaloid have been designed via tandem strategy. A variety of fused triazoles and triazolines with a bis-azahomotwistane skeleton have been prepared. In trifluoroethanol, O-mesylcinchonidine 7-OMs and NaN(3) furnish triazole 8 as well as cage-expanded 1,5-diazatricyclo[4.4.1.0(3,8)]undecane derivative 10. Both fused triazoles 8 and 10 are formed with retention of configuration at C9 and C3, respectively. 1-Azabicyclo[3.2.2]cage expansion is shown to be reversible.
 ...
PMID:Fused triazoles via tandem reactions of activated Cinchona alkaloids with azide ion. Second Cinchona rearrangement exemplified. 1288 71

The formation of self-assembled chemisorbed monolayers (SAM) of 8-amino-1-undecane thiol functionalized with fullerene C(60) on gold, has been studied by contact angle measurements, Fourier transform infrared-attenuated total reflection (FTIR-ATR) spectroscopy, and X-ray photoelectron spectroscopy (XPS). A two-step procedure was followed consisting of the chemisorption of amine-terminated organosulfur compounds, followed by their reaction with fullerenes at the solid-liquid interface. Covalent binding of fullerenes to these attachment layers was accessed by FTIR-ATR and XPS. ATR showed several major features in the C(60) skeleton ring vibration region along with all the characteristic features of the aminothiol. With increase in carbon to sulfur ratio, appearance of a C1s shake-up satellite peak due to the characteristic pi-pi(*) transition of the C(60) backbone and a low binding energy N1s feature confirmed the z.sbnd;NH(2) binding at the 6,6 double bond of the C(60) cage. Possible explanations for these experimental findings are discussed.
 ...
PMID:Binding of fullerene C60 to gold surface functionalized by self-assembled monolayers of 8-amino-1-octane thiol: a structure elucidation. 1461 70

In previous studies, the polycyclic cage amine 8-benzylamino-8,11-oxapentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecane (NGP1-01) and a number of its derivatives showed positive effects in neuroprotection studies with MPTP, in vivo. In view of these findings, we examined these compounds for their effects on [(3)H]dopamine ([(3)H]DA) release and uptake inhibition in murine striatal synaptosomes, as well as for inhibition of baboon liver monoamine oxidase (MAO) B. In order to assess specificity, initial experiments focused on compounds that blocked dopamine uptake without causing appreciable release (<40% at 100 microM) of the transmitter. NGP1-01 blocked the uptake of [(3)H]DA with an IC(50) of 57 microM, while another compound, 8-phenylethyl-8,11-oxapentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecane, blocked uptake at an IC(50) value of 23 microM. These values were comparable to that of another polycyclic cage amine, amantadine (IC(50); 82 micro), that is used in parkinsonian therapy. Structure-activity relationships of this series of compounds support the importance of geometric and steric, rather than electronic effects, in determining biological activity. MAO-B inhibition for this group was weak, with less than 50% inhibition at 300 microM for any of the compounds in the series. The present study suggests that blockage of the dopamine transporter may underlie, at least in part, their neuroprotective effects against MPTP-induced parkinsonism. These compounds may be considered as potential lead compounds for Parkinson's Disease therapy.
 ...
PMID:Synthesis and biological evaluation of pentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecane derivatives as potential therapeutic agents in Parkinson's disease. 1502 70

alpha-Amino acids are important building blocks for the synthesis of a large number of bioactive compounds and pharmaceutical drugs. However, a literature survey revealed that no theoretical conformational study of alpha-amino acids with cage carbon frameworks has been performed to date. This paper reports the results of a conformational study on the (R)-8-amino-pentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecane-8-carboxylic acid monopeptide (cage monopeptide), using molecular mechanics and ab initio methods. The in vacuo Ramachandran maps computed using the different parameterizations of the AMBER force field show the C7eq structure as the most favourable conformation, in contrast to the C7ax structure, that is the lowest energy conformation at the ab initio level. Analysis of these maps reveals the helical preference for the monopeptide and provides the potential for the cage residue to be incorporated into constrained peptide analogues.
 ...
PMID:Computational study of the conformational preferences of the (R)-8-amino-pentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecane-8-carboxylic acid monopeptide. 1516 Aug 39

Three cage-like polycyclic compounds, viz. exo-8-(trifluoromethyl)pentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecan-endo-8-ol, C12H13F3O, 5-(trifluoromethyl)-4-oxahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ol, C12H11F3O2, and N-[exo-11-(trifluoromethyl)-endo-11-(trimethylsilyloxy)pentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecan-8-ylidene]aniline methanol solvate, C21H24F3NOSi.CH4O, were obtained from the corresponding oxo derivatives by nucleophilic trifluoromethylation with (trifluoromethyl)trimethylsilane in 1,2-dimethoxyethane solution in the presence of CsF. The crystal structures show that the addition of trifluoromethanide occurs exclusively from the exo face of the polycyclic ketones. Further examination of the crystal structures, together with that of the starting pentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecane-8,11-dione, C11H10O2, showed that increasing substitution at the 8- and/or 11-positions in the cage molecules increases the non-bonded intramolecular C...C distances at the mouth of the cage and changes the puckering of the five-membered rings involving the 8- and 11-positions from an envelope towards a distorted half-chair conformation. Intermolecular co-operative O-H...O hydrogen bonds in the endo-8-ol compound link the molecules into tetramers.
 ...
PMID:Trifluoromethyl derivatives of pentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecane. 1580 34

The X-ray structure of a di-pentacyclo-undecane cyclic ether was recently reported. As part of a programme to use NMR spectroscopy for the structure elucidation of cage compounds, the complete NMR assignments of the cyclic ether was attempted. Major overlap of proton and carbon signals of the two cages is observed. It was required to elucidate the fragment analogues that represent similar structural features of the cyclic ether in order to get an approximate but reasonable insight into the complex overlapping signals. Normal 2D NMR techniques were utilized to assign the various NMR signals.
 ...
PMID:NMR assignments of a di-pentacyclo-undecane cyclic ether. 1694 77


1 2 3 Next >>